Provided by Tiger Trade Technology Pte. Ltd.

Nasdaq

94.20
+0.55000.59%
Volume:618.85K
Turnover:58.27M
Market Cap:52.66B
PE:27.47
High:94.85
Open:94.27
Low:93.79
Close:93.65
52wk High:101.79
52wk Low:76.55
Shares:559.00M
Float Shares:496.00M
Volume Ratio:0.33
T/O Rate:0.12%
Dividend:1.12
Dividend Rate:1.19%
EPS(TTM):3.43
EPS(LYR):3.09
ROE:16.52%
ROA:5.85%
PB:4.39
PE(LYR):30.49

Loading ...

Vor Bio Says Telitacicept Phase 3 Analysis Shows 42% Minimal Symptom Expression in gMG Through 48 Weeks

Reuters
·
Sep 29

Tectonic Therapeutic Reports Favorable Phase 1a Results for Tx2100 in HHT Program

Reuters
·
Sep 29

Silexion Therapeutics Says Holders Exercise Warrants for 3,216,928 Shares at $0.2603 Each

Reuters
·
Sep 29

Apyx Medical Reports Renuvion Study Shows Increased Elastin, Reduced Inflammation at 180 Days

Reuters
·
Sep 29

Imunon Converts USD 1.2 Million Debt into Newly Issued Preferred Shares

Reuters
·
Sep 29

Brunswick Names Will Sangster President of Navico Group Effective Jan. 1, 2027

Reuters
·
Sep 29

Veracyte Decipher Prostate Test Predicts Benefit of Adding Hormone Therapy to Radiation in Phase III Trial Analysis

Reuters
·
Sep 29

Savaria Chairman Marcel Bourassa Sells Shares for $85.05 Million

Reuters
·
Sep 29

Tokyo Lifestyle Converts JPY 510 Million Shareholder Loan into Equity

Reuters
·
Sep 29

SaverOne Wins New U.S. Patent for Automated Sensor Fusion Calibration Maintenance

Reuters
·
Sep 29

Outdoor Holding to Host Fiscal Q2 Earnings Call

Reuters
·
Sep 29

NewAmsterdam Pharma Doses First Patient in Phase 2b Spinoza Trial of Obicetrapib in Preclinical Alzheimer’s Disease

Reuters
·
Sep 29

Max Power Mining Says Lawson 5 Well Nears Prairie Evaporite Salt Horizon in Natural Hydrogen Step-Out Program

Reuters
·
Sep 29

Byrna Shifts iHeartMedia Ad Spend to Bobby Bones Show to Broaden Mainstream Reach

Reuters
·
Sep 29

Axil Brands Updates Financial Calendar with Upcoming Quarterly Results Release and Investor Call

Reuters
·
Sep 29

Maris-Tech Completes Development of Diamond Ultra V2 Video and AI Platform

Reuters
·
Sep 29

Dianthus Therapeutics to Present Phase 3 Captivate Interim Analysis of Claseprubart in CIDP at 2026 AANEM Meeting

Reuters
·
Sep 29

AgEagle Anti-Jamming Technology Performs Strongly in Army DDIL Testing, Nears Production Readiness

Reuters
·
Sep 29

Phathom Begins Phase 3 Trial of Voquezna As-Needed Dosing in Non-Erosive GERD Patients

Reuters
·
Sep 29

Beta Bionics to Report Q3 2026 Results, Host Conference Call and Webcast

Reuters
·
Sep 29